Geode Capital Management
DICE

Geode Capital Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Geode Capital Management’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-743,341
Closed -$34.5M – 4854
2023
Q2 		$34.5M Buy
743,341
+47,408
+7% +$1.64M ﹤0.01% 1497
2023
Q1 		$19.9M Buy
695,933
+29,107
+4% +$862K ﹤0.01% 1805
2022
Q4 		$20.8M Buy
666,826
+182,224
+38% +$5.94M ﹤0.01% 1747
2022
Q3 		$9.83M Buy
484,602
+103,557
+27% +$1.89M ﹤0.01% 2274
2022
Q2 		$5.91M Buy
381,045
+139,135
+58% +$2.39M ﹤0.01% 2609
2022
Q1 		$4.63M Buy
241,910
+62
+0% +$1.11K ﹤0.01% 2839
2021
Q4 		$6.12M Buy
+241,848
New +$7.09M ﹤0.01% 2773

Geode Capital Management's DICE Position: Q3 2023 in Review

Geode Capital Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 743,341 shares — an estimated $34.5M sold.

Geode Capital Management first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $34.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Geode Capital Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Geode Capital Management sold 743,341 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $34.5M.
  • Geode Capital Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Geode Capital Management's DICE Therapeutics, Inc. Common Stock position peaked at $34.5M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.